CENTOGENE News & Events Header Image Broschure

News

Stay up to date and read about our most recent milestones towards achieving CENTOGENE’s mission: To enable the cure of 100 rare diseases in 10 years.

Interested in receiving the latest news around the clock? Follow us on LinkedIn.

CENTOGENE and Evotec Expand Collaboration Into Gaucher Disease

CAMBRIDGE, Mass., and ROSTOCK/BERLIN/HAMBURG, Germany, August 20, 2020 (Globe Newswire) – Centogene N.V. (Nasdaq: CNTG), a commercial-stage company…

Read more

CENTOGENE und Evotec erweitern Zusammenarbeit für die erweiterte Therapieentwicklung zur angeborenen Erkrankung Morbus Gaucher

CAMBRIDGE, Mass., USA und ROSTOCK/BERLIN/HAMBURG, Deutschland, 20. August 2020: CENTOGENE N.V. (Nasdaq: CNTG), ein wirtschaftliches Unternehmen, das…

Read more

CentoMD® Update Reveals Further Insights Into Rare Diseases

CAMBRIDGE, Mass., and ROSTOCK and BERLIN, Germany, August 11, 2020 – Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on rare…

Read more

CENTOGENE and Molecular Health Announce an Exclusive Collaboration With the Aim to Transform the Development of Orphan Drugs

Cambridge, MA, USA & Rostock/Berlin, Germany, and Heidelberg, Germany, July 27, 2020 (Globe Newswire)

  • The combination of real-life data sets in…

Read more

CENTOGENE und Event Inc bieten gemeinsam Service an: Ab sofort können Nutzer der Buchungsplattform Corona-Tests für die Besucher ihrer Veranstaltungen vorab bestellen

  • CENTOGENE, die Dr. Bauer Laboratoriums GmbH und die Buchungsplattform Event Inc bieten Veranstaltungsbesuchern ab sofort SARS-CoV-2-Tests zum…

Read more

CENTOGENE Announces Pricing of Primary and Secondary Public Offering of Common Shares

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, July 09, 2020 (Globe Newswire) – Centogene N.V. (Nasdaq: CNTG) (“Centogene” or the “Company”), a…

Read more

CENTOGENE Announces Proposed Primary and Secondary Public Offering of Common Shares

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, July 07, 2020 (Globe Newswire) - Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused…

Read more

CENTOGENE Receives FDA Emergency Use Authorization for COVID-19 Molecular Diagnostic Test

Cambridge, MA, USA & Rostock/Berlin, Germany, July 2, 2020 (GLOBE NEWSWIRE) – Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on…

Read more

CENTOGENE Announces Change in Supervisory Board

Cambridge, MA, USA & Rostock/Berlin, Germany, June 23, 2020 (Globe Newswire) – Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on…

Read more

Partnership for OESIS Network

CAMBRIDGE, Mass. and SANTA MONICA, California, June 16, 2020 - In light of the current Coronavirus situation, the OESIS Network Inc and CENTOGENE, a…

Read more

For Further Inquiries Please Contact

Press Contact

Melissa Hall

Corporate Communications

Email Us

Downloads

Here you can find forms, brochures, flyer and information sheets for download (PDF) about the broad genetic testing product and service portfolio of CENTOGENE.

Downloads